Terumo Interventional Systems

Terumo Interventional Systems (TIS) is a global leader in cardiovascular care, focusing on innovative medical devices for interventional cardiology, interventional radiology, and vascular surgery. Founded in Japan, TIS has over 30 years of experience and operates in more than 140 countries, generating approximately $2.3 billion in global business. The company specializes in minimally invasive treatments for conditions affecting the heart, lungs, brain, and blood vessels. Its product portfolio includes access devices for catheter insertion, therapeutic devices like stents and coils, intravascular imaging systems, and interventional oncology devices for targeted chemotherapy delivery. TIS is committed to innovation, exemplified by its RADIFOCUS™ Guidewire and advanced technologies like the R2P™ system and R.A.V.I. for expanding treatment options. TIS also emphasizes education and training through initiatives like Terumo Learning Edge™, collaborating with global partners to enhance learning for interventional procedures. As part of the Terumo Corporation, TIS aims to improve treatment efficacy and quality of life through kind and caring medical care solutions. Its customers include hospitals, catheter labs, interventional cardiologists, radiologists, vascular surgeons, and healthcare providers.

• Employees 300
• Founded 1921